Director, Supply Chain

BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases. Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.

What Are We Doing?

Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies. We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.

Who is BlueRock?

BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases. The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across two therapeutic areas: neurology and immunology.

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit. We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

What Are We Doing?

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.

Description of Position

The Director, Supply Chain is responsible for leading BlueRock Therapeutics' end-to-end supply chain strategy and operations in support of research, process development, clinical manufacturing, and clinical trial execution. As a key member of the Cell Therapy Product Supply Operations organization, this role ensures the reliable, compliant, and scalable supply of critical materials, products, and services required to advance BlueRock's clinical-stage cell therapy portfolio. The Director will establish and lead integrated planning, strategic sourcing, procurement, materials management, inventory control, and distribution capabilities across the organization. This individual will partner closely with Manufacturing, Technical Operations, MSAT, Process Development, Quality, Regulatory, Clinical Operations, and external suppliers to mitigate supply risk, improve operational performance, and enable successful delivery of clinical programs. This leader will oversee teams responsible for procurement, planning, and materials management while building the processes, systems, and organizational capabilities necessary to support the business.

Responsibilities

• Develop and lead an integrated supply planning process that aligns demand, manufacturing capacity, inventory, and sourcing strategies with CMC development plans and clinical program requirements.
• Implement supply chain standards, metrics, and governance to improve forecasting accuracy, inventory performance, and operational execution.
• Lead capacity planning and scenario modeling activities to support program prioritization, resource allocation, and business decision-making.
• Develop sourcing strategies for critical raw materials, consumables, testing services, and outsourced manufacturing activities to ensure continuity of supply and quality.
• Build and maintain strategic partnerships with key suppliers to support clinical development timelines and long-term business objectives.
• Lead cross-functional efforts to identify, assess, and mitigate supply and quality risks associated with critical materials and services.
• Support supplier qualification, performance management, quality agreements, audits, and inspection readiness activities in partnership with Quality.
• Ensure compliant and reliable movement of clinical materials, drug product, patient-specific therapies, and development samples across the network.
• Oversee logistics, import/export activities, permits, chain-of-identity and chain-of-custody requirements, and supporting documentation required for clinical execution.
• Support the development and execution of cold chain and controlled-temperature distribution strategies that will service clinical programs.
• Partner with Clinical Operations and Quality to ensure appropriate labeling, packaging, and distribution controls for clinical investigational products.
• Lead GMP materials management operations, including inventory control, warehousing, replenishment strategies, master data governance, and transactional compliance.
• Serve as the business lead for supply chain-related systems, processes, and digital transformation initiatives, including ERP, inventory management, sourcing, and logistics platforms.
• Establish procedures, controls, and quality systems to ensure accurate inventory records, material traceability, and regulatory compliance.
• Lead and develop a high-performing team of supply chain planners, buyers, and materials management professionals.
• Establish the materials management and supply chain infrastructure, processes, and organizational capabilities required for BlueRock's new Greater Toronto Area operations that is currently under design and construction.
• Foster a culture of operational excellence, collaboration, accountability, and continuous improvement across the supply chain organization.
• Ensure all supply chain activities are conducted in accordance with GMP regulations, BlueRock policies, and applicable global regulatory requirements.
• Maintain inspection-ready operations and support internal audits, regulatory inspections, and quality investigations as required.
• Monitor and report key performance indicators to drive transparency, operational effectiveness, and continuous improvement.

Minimum Requirements

• BS/MS or PhD in a business or scientific field with ≥12+ years of experience of related or equivalent work experience in operation, procurement or supply chain role is required
• Minimum of 5 years of relevant supply chain management and/or project leadership experience is required
• Direct experience with shipments requiring critical/ultra-cold chain constraints, materials, inventory control and warehousing & distribution is required.
• General understanding of pharmaceutical supply chain including serialization is preferred.
• Experience working in GxP pharmaceutical and/or biotechnology regulated environment is required.
• Experience in representing the function as Subject Matter Expert (SME) and defending GxP systems in audit setting is required.
• Highly functional in a fast-paced, dynamic company with ability to adapt to changing timelines and priorities required.
• Excellent written and verbal communication skills are a must.
• Experience with relevant legal standards and compliance systems is required
• Working knowledge of Quality Assurance (QA) and Environmental, Health & Safety (EHS) standards are required.
• Demonstrated application of quality and efficiency improvement methods such as LEAN, Six Sigma is preferred.
• Experience working with contract service providers such as offsite warehouse and logistics is required.
• Experience in working with electronic systems such as ERP, LIMS, CMMS, WMS is required.
• Ability to analyze and resolve problems independently.

Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

The estimated compensation range for this position is $ 190,000.00 - $ 202,050.00 per year.

Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.

BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases.

Two of our novel investigational cell therapies, one for the treatment of Parkinson’s disease and one for the treatment of primary photoreceptor diseases, are clinical stage programs.

BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation.

In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG.

Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.